Adaptive study design and the potential for convalescent plasma therapy in Covid-19 patients

ID-HUB media spoke with José Javier García, Pivotal´s VP, Data Management and Biostatistics, about adaptive study design and the potential for convalescent plasma therapy in Covid-19 patients

To read the full interview please go to the following link: Infectious Diseases Hub media

MEDIA CONTACT

Ms. Natalia Farr

natalia.farr@pivotalcr.com